Evidence map›Paper›PMID 29464168›Full record

ArticlePlastic and reconstructive surgery. Global open2018

Treatment Strategies for Hypopigmentation in the Context of Burn Hypertrophic Scars.

Bonnie C Carney, Jacqueline P McKesey, Dean S Rosenthal, Jeffrey W Shupp

Open access · goldAbstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Exploring the gaps: A scoping review of burn injury research in skin of colour.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bonnie C CarneyDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, D.C.; Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, D.C.; and The Burn Center, MedStar Washington Hospital Center, Washington, D.C.
Jacqueline P McKeseyDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, D.C.; Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, D.C.; and The Burn Center, MedStar Washington Hospital Center, Washington, D.C.
Dean S RosenthalDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, D.C.; Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, D.C.; and The Burn Center, MedStar Washington Hospital Center, Washington, D.C.
Jeffrey W ShuppDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, D.C.; Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, D.C.; and The Burn Center, MedStar Washington Hospital Center, Washington, D.C.
MedStar Washington Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyspigmentation in burn scars can contribute to the development of psychosocial complications after injury and can be detrimental to social reintegration and quality of life for burn survivors. Although treatments for skin lightening to treat hyperpigmentation have been well reviewed in the literature, skin-darkening strategies to treat hypopigmentation have not. The following potential treatment options in the context of burn hypertrophic scar will be discussed: use of the melanocyte-keratinocyte transplantation procedure, use of ectopic synthetic analogues of alpha-melanocyte stimulating hormone to initiate melanogenesis, and use of FK506 to induce melanogenesis. A proposed future direction of research in laser-assisted drug delivery of inducers of local melanin production, with the hope of developing a targeted, effective approach to dyspigmentation in hypertrophic scar is also discussed.

Identifiers

PMID29464168
PMCPMC5811298
OpenAlexW2791221075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.